Literature DB >> 19910452

Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.

Adly Yacoub1, Renyan Liu, Margaret A Park, Hossein A Hamed, Rupesh Dash, Danielle N Schramm, Devanand Sarkar, Igor P Dimitriev, Jessica K Bell, Steven Grant, Nicholas P Farrell, David T Curiel, Paul B Fisher, Paul Dent.   

Abstract

Melanoma differentiation associated gene-7/interleukin 24 (mda-7/IL-24) is a unique interleukin (IL)-10 family cytokine displaying selective apoptosis-inducing activity in transformed cells without harming normal cells. The present studies focused on defining the mechanism(s) by which recombinant adenoviral delivery of MDA-7/IL-24 inhibits cell survival of human ovarian carcinoma cells. Expression of MDA-7/IL-24 induced phosphorylation of protein kinase R-like endoplasmic reticulum kinase (PERK) and eukaryotic initiation factor2alpha (eIF2alpha). In a PERK-dependent fashion, MDA-7/IL-24 reduced ERK1/2 and AKT phosphorylation and activated c-Jun NH(2)-terminal kinase (JNK) 1/2 and p38 mitogen-activated protein kinase (MAPK). MDA-7/IL-24 reduced MCL-1 and BCL-XL and increased BAX levels via PERK signaling; cell-killing was mediated via the intrinsic pathway, and cell killing was primarily necrotic as judged using Annexin V/propidium iodide staining. Inhibition of p38 MAPK and JNK1/2 abolished MDA-7/IL-24 toxicity and blocked BAX and BAK activation, whereas activation of mitogen-activated extracellular-regulated kinase (MEK) 1/2 or AKT suppressed enhanced killing and JNK1/2 activation. MEK1/2 signaling increased expression of the MDA-7/IL-24 and PERK chaperone BiP/78-kDa glucose regulated protein (GRP78), and overexpression of BiP/GRP78 suppressed MDA-7/IL-24 toxicity. MDA-7/IL-24-induced LC3-green fluorescent protein vesicularization and processing of LC3; and knockdown of ATG5 suppressed MDA-7/IL-24-mediated toxicity. MDA-7/IL-24 and cisplatin interacted in a greater than additive fashion to kill tumor cells that was dependent on a further elevation of JNK1/2 activity and recruitment of the extrinsic CD95 pathway. MDA-7/IL-24 toxicity was enhanced in a weak additive fashion by paclitaxel; paclitaxel enhanced MDA-7/IL-24 + cisplatin lethality in a greater than additive fashion via BAX. Collectively, our data demonstrate that MDA-7/IL-24 induces an endoplasmic reticulum stress response that activates multiple proapoptotic pathways, culminating in decreased ovarian tumor cell survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910452      PMCID: PMC2812067          DOI: 10.1124/mol.109.061820

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  48 in total

1.  Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas.

Authors:  S Ekmekcioglu; J Ellerhorst; A M Mhashilkar; A A Sahin; C M Read; V G Prieto; S Chada; E A Grimm
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

2.  Loss of MDA-7 expression with progression of melanoma.

Authors:  Julie A Ellerhorst; Victor G Prieto; Suhendan Ekmekcioglu; Lyle Broemeling; Sandra Yekell; Sunil Chada; Elizabeth A Grimm
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

3.  Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c.

Authors:  M E Guicciardi; J Deussing; H Miyoshi; S F Bronk; P A Svingen; C Peters; S H Kaufmann; G J Gores
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells.

Authors:  Irina V Lebedeva; Zao-zhung Su; Yonmee Chang; Shinichi Kitada; John C Reed; Paul B Fisher
Journal:  Oncogene       Date:  2002-01-24       Impact factor: 9.867

5.  Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.

Authors:  E Y Huang; M T Madireddi; R V Gopalkrishnan; M Leszczyniecka; Z Su; I V Lebedeva; D Kang; H Jiang; J J Lin; D Alexandre; Y Chen; N Vozhilla; M X Mei; K A Christiansen; F Sivo; N I Goldstein; A B Mhashilkar; S Chada; E Huberman; S Pestka; P B Fisher
Journal:  Oncogene       Date:  2001-10-25       Impact factor: 9.867

6.  The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.

Authors:  Eva G Caudell; John B Mumm; Nancy Poindexter; Suhendan Ekmekcioglu; Abner M Mhashilkar; Xiaohong Helena Yang; Mark W Retter; Paul Hill; Sunil Chada; Elizabeth A Grimm
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions.

Authors:  Julia Parrish-Novak; Wenfeng Xu; Ty Brender; Lena Yao; Crystal Jones; Jim West; Cameron Brandt; Laura Jelinek; Karen Madden; Patricia A McKernan; Donald C Foster; Stephen Jaspers; Yasmin A Chandrasekher
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

8.  mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

Authors:  Devanand Sarkar; Zao-Zhong Su; Irina V Lebedeva; Moira Sauane; Rahul V Gopalkrishnan; Kristoffer Valerie; Paul Dent; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

Review 9.  Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice.

Authors:  Atsushi Matsuzawa; Hideki Nishitoh; Kei Tobiume; Kohsuke Takeda; Hidenori Ichijo
Journal:  Antioxid Redox Signal       Date:  2002-06       Impact factor: 8.401

10.  MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.

Authors:  Margaret A Park; Teneille Walker; Aditi Pandya Martin; Jeremy Allegood; Nicollaq Vozhilla; Luni Emdad; Devanand Sarkar; Mohammed Rahmani; Martin Graf; Adly Yacoub; Costas Koumenis; Sarah Spiegel; David T Curiel; Christina Voelkel-Johnson; Steven Grant; Paul B Fisher; Paul Dent
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

View more
  24 in total

Review 1.  Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?

Authors:  David S Hill; Penny E Lovat; Nikolas K Haass
Journal:  Melanoma Manag       Date:  2014-12-04

2.  Hesperidin inhibits ovarian cancer cell viability through endoplasmic reticulum stress signaling pathways.

Authors:  Jun Zhao; Yali Li; Jinfang Gao; Yinshan De
Journal:  Oncol Lett       Date:  2017-09-01       Impact factor: 2.967

3.  Characterization of the canine mda-7 gene, transcripts and expression patterns.

Authors:  Maninder Sandey; R Curtis Bird; Swadesh K Das; Devanand Sarkar; David T Curiel; Paul B Fisher; Bruce F Smith
Journal:  Gene       Date:  2014-05-24       Impact factor: 3.688

Review 4.  The development of MDA-7/IL-24 as a cancer therapeutic.

Authors:  Paul Dent; Adly Yacoub; Hossein A Hamed; Margaret A Park; Rupesh Dash; Sujit K Bhutia; Devanand Sarkar; Xiang-Yang Wang; Pankaj Gupta; Luni Emdad; Irina V Lebedeva; Moira Sauane; Zhao-zhong Su; Mohamed Rahmani; William C Broaddus; Harold F Young; Maciej S Lesniak; Steven Grant; David T Curiel; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2010-08-21       Impact factor: 12.310

Review 5.  MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.

Authors:  Paul Dent; Adly Yacoub; Hossein A Hamed; Margaret A Park; Rupesh Dash; Sujit K Bhutia; Devanand Sarkar; Pankaj Gupta; Luni Emdad; Irina V Lebedeva; Moira Sauane; Zhao-Zhong Su; Mohamed Rahmani; William C Broaddus; Harold F Young; Maciej Lesniak; Steven Grant; David T Curiel; Paul B Fisher
Journal:  Anticancer Drugs       Date:  2010-09       Impact factor: 2.248

6.  Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Authors:  Lin Wang; Zhien Feng; Huanhuan Wu; Shuai Zhang; Yinfei Pu; Huan Bian; Yixiang Wang; Chuanbin Guo
Journal:  Tumour Biol       Date:  2014-08-05

7.  Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells.

Authors:  Wei Wu; Hai-Dong Wang; Wei Guo; Kang Yang; Yun-ping Zhao; Yao-guang Jiang; Ping He
Journal:  J Exp Clin Cancer Res       Date:  2010-05-14

8.  Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.

Authors:  Gangadharan B Sajithlal; Hossein A Hamed; Nichola Cruickshanks; Laurence Booth; Seyedmehrad Tavallai; Jahangir Syed; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Mol Pharmacol       Date:  2013-07-22       Impact factor: 4.436

9.  Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance.

Authors:  Timothy Webb; Jori Carter; Jane L Roberts; Andrew Poklepovic; William P McGuire; Laurence Booth; Paul Dent
Journal:  Cancer Biol Ther       Date:  2015-09-29       Impact factor: 4.742

Review 10.  MDA-7/IL-24: multifunctional cancer killing cytokine.

Authors:  Mitchell E Menezes; Shilpa Bhatia; Praveen Bhoopathi; Swadesh K Das; Luni Emdad; Santanu Dasgupta; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.